Clinical Trial Update: RAB001（LLP2A-Ale） in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial of RAB001 (LLP2A-Ale) in healthy subjects has completed, studying its use for osteonecrosis of the femoral head.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteonecrosis of the Femoral Head

Drugs mentioned

• RAB001 (LLP2A-Ale) (LLP2A-Ale)

Snippet

Sponsor: ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. | Conditions: Osteonecrosis of the Femoral Head | Phase 1 | Status: COMPLETED